The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
Open accessAbstract
T he incidence of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread rapidly globally; as of March 29, 2020, ≈670,000 cases had been confirmed worldwide (1).COVID-19 is typically a pulmonary infection that can range from mild illness to acute respiratory distress syndrome and multiple organ failure; however, other symptoms such as myalgias and anorexia have been noted (2).Although many ongoing studies are investigating measurement of proinflammatory cytokines and other biomarkers as a way to prognosticate infection severity, we investigated use of 2 easily obtained predictors: lymphopenia and leukocytosis (3). The StudyWe searched 3 major databases-MEDLINE/ PubMed, EMBASE, and CENTRAL (Cochrane Central Register of Controlled Trials)-for clinical studies published December 1, 2019, through March 28, 2020.To broadly identify studies detailing lymphocyte and leukocyte testing among patients with COVID-19, we used the following search criteria: "(COVID-19 OR SARS-CoV-2 OR 2019-NCoV OR HCov-19 OR novel coronavirus) AND (laboratory OR WBC OR lymphocyte)."We prioritized studies that measured lymphocyte and leukocyte counts among patients who had severe or critical cases versus those with mild cases.Severe cases were defined as significant respiratory distress (acute hypoxic respiratory failure, acute respiratory distress syndrome, need for mechanical ventilation, or intensive care unit admission) caused by COVID-19.Our meta-analysis included articles about studies and clinical trials that met the following 4 inclusion criteria: 1) involved adult, human patients; 2) written in English; 3) reported lymphocyte and leukocyte counts for patients; and 4) compared patients with severe versus mild illness.Our meta-analysis excluded articles about studies with the following 9 characteristics: 1) involved nonhuman subjects; 2) written in a language other than English; 3) were not a clinical trial, such as a review paper or letter; 4) were out of the scope of the study question detailed above; 5) did not provide raw data to perform quantitative metaanalysis; 6) involved pediatric patients; 7) did not have the full article available; 8) were duplicates; and 9) were ongoing or not completed.We performed the meta-analysis by using Review Manager software version 5.3 (The Cochrane Collaboration, https://training.cochrane.org).We calculated mean differences (MDs) between groups for continuous variables and reported 95% CIs for both severe and nonsevere cases.If the included studies provided medians and interquartile ranges instead of MDs and SDs, we imputed the MDs and SDs as described previously (4-6) and additionally described in the Cochrane Handbook for Systematic Reviews (7).We considered results statistically insignificant if p>0.05 or if the MD included zero.We assessed statistical heterogeneity by using the I 2 statistic and awarded the following values: 0%-24%, homogeneity; 25%-49%, mild heterogeneity; 50%-74%, moderate heterogeneity; and >75%, high Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
Luo, D., Wan, X., Liu, J., & Tong, T. (2018) · Statistical Methods in Medical Research · doi:10.1177/0962280216669183 · Cited by 4,066
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25783 · Cited by 982
Self-citationQian, G. Q., Yang, N. B., Ding, F., Ma, A. H. Y., Wang, Z. Y., Shen, Y. F., Shi, C. W., Lian, X., Chu, J. G., Chen, L., et al. (2020) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcaa089 · Cited by 382
Cited by
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
COVID-19 in 7780 pediatric patients: A systematic review
Hoang, A., Chorath, K., Moreira, A., Evans, M., Burmeister-Morton, F., Burmeister, F., Naqvi, R., Petershack, M., & Moreira, A. (2020) · eClinicalMedicine · doi:10.1016/j.eclinm.2020.100433 · Cited by 533
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children
Kompaniyets, L., Agathis, N. T., Nelson, J. M., Preston, L. E., Ko, J. Y., Belay, B., Pennington, A. F., Danielson, M. L., DeSisto, C. L., Chevinsky, J. R., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.11182 · Cited by 401
Metadata
- Authors
- Huang, G., Kovalic, A. J., & Graber, C. J.
- Venue
- Emerging Infectious Diseases
- Published
- 2020-08
- Volume
- 26
- Issue
- 8
- Pages
- 1839-1841
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W3021698968
- Cited by
- 167
- References
- 5
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity. https://app.cochat.ai/papers/10.3201/eid2608.201160
- The paper
- Huang, G., Kovalic, A. J., & Graber, C. J. (2020). Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity. Emerging Infectious Diseases. https://doi.org/10.3201/eid2608.201160
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.